About us
- >
- About us >
- Information >
- Announcement
2024-10-11
EB Announces Exclusive Licensing Agreement with PBI Portugal Unipessoal Lda., a wholly owned subsidiary of the German group Pharma Bavaria International
Energenesis Biomedical CO., LTD has entered into an exclusive licensing agreement with PBI Portugal Unipessoal Lda., a wholly owned subsidiary of the renowned German pharmaceutical group, PBI. The agreement grants PBI thecommercial rights in Portugal and the Middle East for the use of ENERGI-F703DFU in the treatment of diabetic foot ulcers.The markets in Africa and Central America will be phased in based on development milestones, as agreed upon by both parties.